secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELEFLEX INC (TFX)
CIK:        0000096943
Form:       8-K
Filed at:   2023-08-03T23:59:59+00:00
Accession:  0000096943-23-000088
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teleflex Q2 revenue up 5.9% constant currency; revenue guidance raised, adjusted EPS maintained
--------------------------------------------------------------------------------

- Q2 revenues $743.3M, +5.9% constant currency YoY; GAAP diluted EPS $2.35, adjusted diluted EPS $3.41.
- FY2023 GAAP revenue growth guidance raised to 5.80%-6.55%; constant currency raised to 5.50%-6.25%.
- FY2023 GAAP diluted EPS guidance lowered to $7.33-$7.93; adjusted diluted EPS maintained at $13.00-$13.60.
- Announced acquisition of Palette Life Sciences AB for rectal spacer to expand Interventional Urology franchise.
- Interventional Urology constant currency revenue declined 2.3% YoY; OEM segment grew 19.8% constant currency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/96943/000009694323000088/0000096943-23-000088-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/96943/000009694323000088/tfx-20230803.htm
  HTML page:      https://secwatch.observer/filing/0000096943-23-000088

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer